Analysts' Actions: ADM CL INTC MO STI
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Archer-Daniels-Midland (ADM) was downgraded at BMO Capital. Valuation call, based on a $32 price target, BMO Capital said.
Atmel (ATML) was downgraded at FBR Capital Markets from outperform to market perform. $7.50 price target. Company may lose market share in the near term, FBR Capital Markets said.
AZZ (AZZ) was upgraded from neutral to buy at DA Davidson. Estimates were also boosted, as the recent acquisition should add to earnings. DA Davidson said.
Chemtura (CHMT) was downgraded at Oppenheimer to perform from outperform. Approaching limits to further margin improvement, Oppenheimer said. Colgate-Palmolive (CL) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $119 price target. Company is facing difficult comps and a currency headwind, BofA/Merrill Lynch said. CVR Refining (CVRR) was initiated with a neutral rating at Citigroup. $30 price target. Highly defensible position with modest upside, Citi said. CVR Refining LP was initiated with a buy rating at UBS. $31 price target. Yielding fruit of Midwest refining bonanza. Ford (F) was upgraded to buy at TheStreet Ratings. GM (GM) was upgraded to buy at TheStreet Ratings. Intel (INTC) was upgraded at Drexel Hamilton from sell to hold. $22 price target. Altera foundry deal should help future earnings, Drexel Hamilton said. LSI (LSI) was downgraded at FBR Capital Markets from outperform to market perform. $8 price target. Company is facing increased competition, FBR Capital Market said. Altria (MO) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $36 price target. Company will likely face increased competition from RAI, BofA/Merrill Lynch said. Rosetta Resources (ROSE) was downgraded at Miller Tabak to sell. $41 price target. Company is running out of oil inventory, Miller Tabak said. Suntrust Banks (STI) was upgraded at FIG Partners to outperform. $32 price target. Expect positive results from the CCAR stress test, FIG Partners said.STOCK COMMENTS / EPS CHANGES
Autodesk (ADSK) estimates, price target were raised at Credit Suisse. Shares are now seen reaching $35. Estimates were also increased, as the company is signing more large deals, Credit Suisse said. Amgen (AMGN) estimates, target boosted at Guggenheim. Shares are now seen reaching $95. Estimates were also increased, as Epogen is facing less competition, following the Omontys recall, Guggenheim said. Neutral rating. Best Buy (BBY) price target was raised at UBS. Shares are now seen reaching $18. Prolonged stability is now needed to justify BBY's price move, UBS said. Neutral rating. Chuy's Holdings (CHUY) numbers were raised at Jefferies. Shares are now seen reaching $25. Estimates were also raised on unit growth. Hold rating. Capital One Financial (COF) numbers were lowered at Jefferies. Shares are now seen reaching $60. Estimates were also lowered on Best Buy card portfolio sale. Buy rating. Darden Restaurants (DRI) numbers were lowered at Oppenheimer. Shares are now seen reaching $51. Estimates were also lowered on uncertainty surrounding EPS growth, Oppenheimer said. Outperform rating. FirstEnergy (FE) numbers were cut at Credit Suisse. Shares are now seen reaching $46. Estimates were also reduced, as the company will likely issue more equity later this year, Credit Suisse said. Outperform rating. JM Smucker (SJM) numbers were increased at Keybanc. Estimates were raised through 2014. Company is focused on organic growth and improving efficiency, Keybanc said. Buy rating and new $100 price target. >To submit a news tip, email: tips@thestreet.com.Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV